My NCBI | Sign In
RSS Settings
  • Search: Swider C[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

    Perl AE, Kasner MT, Tsai DE, Vogl DT, Loren AW, Schuster SJ, Porter DL, Stadtmauer EA, Goldstein SC, Frey NV, Nasta SD, Hexner EO, Dierov JK, Swider CR, Bagg A, Gewirtz AM, Carroll M, Luger SM.

    Clin Cancer Res. 2009 Nov 1;15(21):6732-9. Epub 2009 Oct 20.PMID: 19843663 [PubMed - in process]Related articles

    2.

    A robust xenotransplantation model for acute myeloid leukemia.

    Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR, Bagg A, Choi JK, Biegel JA, Danet-Desnoyers G, Carroll M.

    Leukemia. 2009 Nov;23(11):2109-17. Epub 2009 Jul 23.PMID: 19626050 [PubMed - in process]Related articles

    3.

    A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.

    Tsai DE, Luger SM, Andreadis C, Vogl DT, Kemner A, Potuzak M, Goradia A, Loren AW, Perl AE, Schuster SJ, Porter DL, Stadtmauer EA, Goldstein SC, Thompson JE, Swider C, Bagg A, Mato AR, Carroll M.

    Clin Cancer Res. 2008 Sep 1;14(17):5619-25.PMID: 18765556 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.

    Hexner EO, Serdikoff C, Jan M, Swider CR, Robinson C, Yang S, Angeles T, Emerson SG, Carroll M, Ruggeri B, Dobrzanski P.

    Blood. 2008 Jun 15;111(12):5663-71. Epub 2007 Nov 5.PMID: 17984313 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.

    Tsai DE, Luger SM, Kemner A, Swider C, Goradia A, Tomczak E, DiPatri D, Bagg A, Nowell P, Loren AW, Perl A, Schuster S, Thompson JE, Porter D, Andreadis C, Stadtmauer EA, Goldsteini S, Ghalie R, Carroll M.

    Cancer Biol Ther. 2007 Jan;6(1):18-21.PMID: 17204865 [PubMed - indexed for MEDLINE]Related articles

    6.

    2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing.

    Kalota A, Karabon L, Swider CR, Viazovkina E, Elzagheid M, Damha MJ, Gewirtz AM.

    Nucleic Acids Res. 2006 Jan 18;34(2):451-61. Print 2006.PMID: 16421272 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules.

    Opalinska JB, Kalota A, Gifford LK, Lu P, Jen KY, Pradeepkumar PI, Barman J, Kim TK, Swider CR, Chattopadhyaya J, Gewirtz AM.

    Nucleic Acids Res. 2004 Oct 28;32(19):5791-9. Print 2004.PMID: 15514112 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

    Shetzline SE, Rallapalli R, Dowd KJ, Zou S, Nakata Y, Swider CR, Kalota A, Choi JK, Gewirtz AM.

    Blood. 2004 Sep 15;104(6):1833-40. Epub 2004 Jun 8.PMID: 15187020 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis.

    Swider C, Schnittger L, Bogunia-Kubik K, Gerdes J, Flad H, Lange A, Seitzer U.

    Eur Cytokine Netw. 1999 Jun;10(2):143-6.PMID: 10400819 [PubMed - indexed for MEDLINE]Related articles

    10.

    Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.

    Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Richter E, Zabel P, Müller-Quernheim J, Flad HD, Gerdes J.

    Cytokine. 1997 Oct;9(10):787-90.PMID: 9344512 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients.

    Lange A, Karabon L, Klimczak A, Dłubek D, Bogunia-Kubik K, Swider C, Suchnicki K.

    Transplant Proc. 1996 Dec;28(6):3522-5. No abstract available. PMID: 8962369 [PubMed - indexed for MEDLINE]Related articles

    12.

    IL-6 is present in sera of bone marrow-transplanted patients in aplastic period and high levels of IL-6 during acute graft-versus-host disease are associated with severe gut symptoms.

    Karabon L, Moniewska A, Laba A, Swider C, Lange A.

    Ann N Y Acad Sci. 1995 Jul 21;762:439-42. No abstract available. PMID: 7668551 [PubMed - indexed for MEDLINE]Related articles

    13.

    Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis.

    Swider C, Laba A, Moniewska A, Gerdes J, Flad HD, Lange A.

    Clin Exp Immunol. 1995 Jun;100(3):401-5.PMID: 7774049 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Betakid--lessons learned while developing a microcomputer pediatric case simulation.

    Wheeler LA, Golden MP, Wheeler ML, Swider C, Price M, Marrero DG, Gray D, Buckley GF, Golden DJ.

    Diabetes Educ. 1987 Fall;13(4):402-5. No abstract available. PMID: 3311675 [PubMed - indexed for MEDLINE]Related articles

    15.

    Evaluation of computer-based diet education in persons with diabetes mellitus and limited educational background.

    Wheeler LA, Wheeler ML, Ours P, Swider C.

    Diabetes Care. 1985 Nov-Dec;8(6):537-44.PMID: 3908024 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    4 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity